|
|
Duke Radiation Oncology News
- Duke Radiation Oncology is the first clinic in the world to use the Novalis Tx™ System. The Novalis Tx™ radiosurgery system delivers high-energy radiation beams to the tumor target at twice the resolution of conventional treatment machines. The increased precision of the Novalis Tx™ is a dramatic improvement in radiosurgery technology, which allows physicians to aim high-dose radiation beams at tumors while minimizing damage to nearby healthy tissue. In addition to minimizing radiation-treatment side effects, this system provides greater ease and comfort for the patient. Radiosurgery treatments that used to take hours to set up and verify are now completed in one hour, and with greater accuracy. The system can quickly verify patient position within one millimeter. Duke Radiation Oncology is leading the way in this new treatment technology.
Varian Novalis Tx System
Announcements and Awards for 2009
Awards in 2008
-
James Oleson, M.D., Ph.D., was awarded the ASTRO Fellow Award in September. To be eligible for this prestigious award, ASTRO members must be a part of the Society for at least 20 years and have served in a leadership role in the organization and have made significant contributions to radiation oncology.
- Mark W. Dewhirst, D.V.M., Ph.D., received the 2008 Faila Award and Lectureship, which is awarded by the Radiation Research Society for distinguished careers in radiation research. Dr. Dewhirst was presented with the Faila Award at the 54th Annual Meeting of the Radiation Research Society in Boston on September 21. Dr. Dewhirst is the Gustavo Montana Professor of Radiation Oncology at Duke University and program director for the Hyperthermia Research and Treatment Program.
- Greg Palmer won the Jack Fowler award from the Radiation Research Society. Greg Palmer, Ph.D., is a Research Associate in the Tumor Microcirculation Laboratory. The Jack Fowler award recognizes an outstanding junior investigator for exceptional research efforts in radiation oncology, medical physics, or radiobiology.
- In January, David G. Kirsch, M.D., Ph.D., received one of the first Damon Runyon-Rachleff Innovation Awards. These new awards apply venture-capital type "investing" in young researchers with innovative approaches to curing cancer. Dr. Kirsch is an Associate Professor at Duke Radiation Oncology who combines research with clinical practice in the treatment of bone and soft tissue sarcomas.
- Several Radiation Oncology clinical nurses have been recognized for their outstanding efforts.
Carolyn Scott was named one of the 100 Great Nurses in North Carolina for 2008. This achievement was featured in Inside Duke Medicine.
Betsy Wyman and Eileen Duffy were both nominated this year for Duke's Friends of Nursing Excellence in Nursing Award.
|